Clinical

  • Clinical Solutions
  • AI solutions portfolio

Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.

Learn more

Research

  • Research solutions
  • Aiforia® Create
  • AI solutions portfolio

Aiforia’s research solutions offer fully automated study-centric workflows and pathology image analysis applications that cater to all research areas. Empowered by robust AI capabilities, pathologists and scientists can make discoveries while saving time by automating repetitive tasks – also within the framework of GLP. Aiforia’s solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.

Learn more

Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.Learn more >

Learn more

Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.

Learn more

AI development tool

  • Aiforia® Create

Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.

Learn more

Resources

  • Publications
  • Resource Library
  • Press releases

Explore some of our latest publications showcasing the discoveries enabled by the Aiforia® Platform.

Learn more

Aiforia's insights and resources for AI in pathology. View some of our content pieces from the world of AI.

Learn more

Stay updated with Aiforia’s recent announcements. Explore our latest news, updates and announcements.

Learn more

Company

  • About us
  • Investors
  • Partners
  • Media
  • Events
  • Careers
  • Quality and security

Find out more about shareholder matters, investment discussions, and financial-related information.

Learn more

Aiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient. To succeed, we need our trusted partners. Explore Aiforia’s partner network.

Learn more

Experience our AI solutions firsthand. Explore the list of conferences where you can connect with Aiforia’s team live and book a time to discover the future of AI-powered image analysis.

Learn more

Our mission is to transform pathology image analysis with AI, enabling better care for each patient. Find out more about job openings, thesis opportunities, or submitting applications.

Learn more

Aiforia Technologies holds information security to the highest standard. We hold several, globally relevant quality and security certifications, so you can be sure your sensitive information is safe.

Learn more

Research

Research solutions

Aiforia® Create

AI solutions portfolio

AI development tool

Aiforia® Create

Resources

Publications

Resource Library

Press releases

Case study: automating the detection of malaria parasites in blood smear

AI-assisted analysis of malaria parasites has the potential to significantly improve diagnosis and treatment of the deadly disease. Learn more.
Written by Aiforia

Malaria is a life-threatening disease caused by Plasmodium parasites and transmitted through the bites of infected female Anopheles mosquitoes. Five parasite species cause malaria in humans, of which P. falciparum and P. vivax pose the greatest threat, often progressing to severe illness, multi-organ failure, or death.

In 2020, nearly half of the world's population was at risk of malaria, with an estimated 241 million malaria cases globally, particularly affecting children under the age of 5, accounting for 67% of deaths worldwide. Most malaria cases and deaths occur in sub-Saharan Africa. The WHO African Region holds about 95% of cases and deaths globally.

Traditional testing methods

There are multiple techniques available to detect malarial parasites, such as clinical diagnosis, polymerase chain reaction (PCR), microscopic diagnosis, and rapid diagnostic test (RDT). Efficiency and accuracy of clinical diagnosis and PCR methods depend on laboratory settings and the level of available expertise, limited commodities in unreached remote areas. The most common tests are, therefore, microscopy and RDT. However, RDT struggles from lack of sensitivity, high costs, and inability to quantify parasite density and differentiate among some species. It is also highly susceptible to damage by heat and humidity, conditions that favor malaria transmission.

Microscopic examination of Giemsa-stained blood smears, taken from a finger prick, is the easiest and most reliable test for malaria. Thick blood smears are most useful for detecting parasite density, which affects whether medicine is provided intravenously instead of orally. Thin blood smears are analyzed to detect the type of parasite present. For example, malaria caused by P. falciparum is more serious than other types and may need different treatment. Microscopy techniques remain the gold standard for laboratory confirmation of malaria. However, accuracy depends on the quality of the reagents, the microscope, and the experience of a trained microscopist.

AI-powered diagnosis

Detecting malaria parasites in blood smear can be time-consuming, laborious, and error-prone with conventional microscopy. Combined with limited training of lab technicians, current diagnostic methods are not enough for the large amount of malaria cases in developing countries. Deep learning AI-based methods have the potential to automate the process, aiding lab technicians in optimizing their time and increasing accuracy and efficiency.

AI models can be trained using annotated datasets to find parasites in blood smears, such as Aiforia's AI software demonstrates in the video below. Through simple annotation of infected cells to train the algorithm, the automation process includes quantifying parasite density faster and more accurately than human-based microscopy. This reduces turnaround time, improves diagnostic performance, and provides consistent and accurate care to patients in a timely manner.

 

Automated image analysis is particularly beneficial for malaria diagnosis in restricted resource environments where the trained workforce is limited. Healthcare professionals can focus on preparing the slides of blood samples, verifying the results, and tending to patients. AI image analysis solutions are not constrained to malaria detection and can be applied to any microscopical assessment, redefining the future of diagnostics.

Learn more about Aiforia's research solutions →

 

References

Fuhad, K. (2020, May). Deep learning based automatic malaria parasite detection from blood smear and its smartphone based application. Diagnostic (Basel), 10(5), 329. https://doi.org/10.3390%2Fdiagnostics10050329 

Linder, N. et al. (2014, August 21). A malaria diagnostic tool based on computer vision screening and visualization of plasmodium falciparum candidate areas in digitized blood smears. Plos One. https://doi.org/10.1371/journal.pone.0104855 

University of Michigan Health. (2020). Thick and Thin Blood Smears for Malaria. https://www.uofmhealth.org/health-library/hw118744 

World Health Organization. (2020). World malaria report 2020. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020 

World Health Organization. (2013). Malaria. https://www.who.int/news-room/fact-sheets/detail/malaria